Cresco Labs (CRLBF) Total Non-Current Liabilities (2019 - 2026)

Cresco Labs has reported Total Non-Current Liabilities for 8 years, with the latest figure at $856.5 million in Q1 2026.

• For the quarter ending Q1 2026, Total Non-Current Liabilities fell 2.15% year-over-year to $856.5 million; the trailing twelve-month figure through Mar 2026 stood at $856.5 million (down 2.15% YoY), and the FY2025 full-year result was $844.6 million, down 3.23% from the prior year.
• Total Non-Current Liabilities for Q1 2026 stood at $856.5 million, up from $844.6 million in the prior quarter.
• The five-year high for Total Non-Current Liabilities was $885.5 million in Q2 2025, with the low at $689.2 million in Q2 2022.
• Historically, Total Non-Current Liabilities has averaged $784.0 million across 5 years, with a median of $740.1 million in 2022.
• Annual changes were most pronounced in 2022 — Total Non-Current Liabilities surged 64.23% — and 2025, when it slipped 3.23%.
• Cresco Labs' Total Non-Current Liabilities stood at $740.1 million in 2022, then dropped by 1.35% to $730.2 million in 2023, then gained by 19.54% to $872.8 million in 2024, then dropped by 3.23% to $844.6 million in 2025, then gained by 1.4% to $856.5 million in 2026.
• The last three Total Non-Current Liabilities figures came in at $856.5 million (Q1 2026), $844.6 million (Q4 2025), and $842.8 million (Q3 2025), per Business Quant data.